Protective Effects of Idebenone against Sepsis Induced Acute Lung Damage. Issue 3 (7th February 2022)

• Record Type: Journal Article
• Authors: Akpinar, Erol; Kutlu, Zerrin; Kose, Duygu; Aydin, Pelin; Tavaci, Taha; Bayraktutan, Zafer; Yuksel, Tugba Nurcan; Yildirim, Serkan; Eser, Gizem; Dincer, Busra
• Is Part Of: Journal of investigative surgery. Volume 35:Issue 3(2022)
• Page Start: 560
• Page End: 568
• Publication Date: 2022-02-07
• Subjects: Idebenone -- sepsis -- antioxidantlung injuryrat -- oxidative stress; Surgery -- Research -- Periodicals; Research; Surgery; Surgical Procedures, Operative; 617.075
• DOI: 10.1080/08941939.2021.1898063
• Languages: English
• ISSNs: 0894-1939

Abstract

Abstract: Background/Aims: Sepsis is an uncontrolled systemic infection, withcomplex pathophysiology that may result in acute lung organ damage and cause multiple organ failure. Although much research has been conducted to illuminate sepsis's complex pathophysiology, sepsis treatment protocols are limited, and sepsis remains an important cause of mortality andmorbidity in intensive care units.Various studies have shown that idebenone (IDE) possesses strong antioxidant properties, which inhibit lipid peroxidation and protect cells from oxidative damage. The present study aimed to evaluate the protective effects of IDE against lung injury in a cecal ligation and puncture (CLP)-induced sepsis rat model. Methods: Male albino Wistar rats were used. The animals were divided into a healthy control (no treatment), CLP, IDE control (200 mg/kg), and CLP + IDE subgroups (50 mg/kg, 100 mg/kg, and 200 mg/kg), with nine rats in each group.IDE was administered 1 h after CLP induction.To evaluate the protective effects of IDE, lung tissues were collected 16 h after sepsis for biochemical, immunohistochemical staining, and histopathological examination. Results: IDE significantly ameliorated sepsis-induced disturbances in oxidative stress-related factors, with its effects increasing in accordance with the dose.IDE also abolished histopathological changes in lung tissues associated with CLP.Furthermore, interleukin 1 beta (IL-1β)and tumor necrosis factor-alpha (TNF-α) immunopositivity markedly decreased in the septic rats following IDE treatment. Conclusions: IDE largely mitigated the inflammatory response in sepsis-induced lung injury by decreasing free radicals and preventing lipid peroxidation. The results suggest that IDE may represent a potential novel therapeutic drug for sepsis treatment.